Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012 (2012), Article ID 925807, 6 pages
http://dx.doi.org/10.1155/2012/925807
Review Article

Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol

1Health Care Center, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
2Clinical Research Center, Kyushu Medical Center, National Hospital Organization, Fukuoka 810-8563, Japan
3Department of Gastroenterology, Kyushu Medical Center, National Hospital Organization, Fukuoka 810-8563, Japan

Received 21 November 2011; Accepted 30 January 2012

Academic Editor: Manuela Neuman

Copyright © 2012 Munechika Enjoji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [27 citations]

The following is the list of published articles that have cited the current article.

  • Mangesh R. Pagadala, and Arthur J. McCullough, “Non-Alcoholic Fatty Liver Disease and Obesity: Not All About Body Mass Inde x,” American Journal of Gastroenterology, vol. 107, no. 12, pp. 1859–1861, 2012. View at Publisher · View at Google Scholar
  • Munechika Enjoji, Motoyuki Kohjima, Kazuhiro Kotoh, and Makoto Nakamuta, “Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments,” International Journal of Hepatology, vol. 2012, pp. 1–7, 2012. View at Publisher · View at Google Scholar
  • Anabel García-Heredia, Elizabeth Kensicki, Robert P. Mohney, Anna Rull, Iris Triguero, Judit Marsillach, Carmen Tormos, Bharti Mackness, Michael Mackness, Diana M. Shih, Juan Pedro-Botet, Jorge Joven, Guillermo Sáez, and Jordi Camps, “Paraoxonase-1 Deficiency Is Associated with Severe Liver Steatosis in Mice Fed a High-fat High-cholesterol Diet: A Metabolomic Approach,” Journal of Proteome Research, vol. 12, no. 4, pp. 1946–1955, 2013. View at Publisher · View at Google Scholar
  • Shira Zelber-Sagi, Federico Salomone, Hanny Yeshua, Roni Lotan, Muriel Webb, Zamir Halpern, Erwin Santo, Ran Oren, and Oren Shibolet, “Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease,” Liver International, 2013. View at Publisher · View at Google Scholar
  • Yumi Hayashi, Yukie Yanagiba, Juncai Wang, Katsumi Ikeda, Yukio Yamori, Tamie Nakajima, Hisao Naito, Hazuki Tamada, Dong Wang, Xiaofang Jia, Husna Yetti, and Kazuya Kitamori, “Dysregulated Bile Acid Synthesis, Metabolism and Excretion in a High Fat-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats,” Digestive Diseases And Sciences, vol. 58, no. 8, pp. 2212–2222, 2013. View at Publisher · View at Google Scholar
  • Sirle Laos, Antoni Caimari, Anna Crescenti, Jamileh Lakkis, Francesc Puiggros, Lluis Arola, and Josep Maria del Bas, “Long-term intake of soyabean phytosterols lowers serum TAG and NEFA concentrations, increases bile acid synthesis and protects against fatty liver development in dyslipidaemic hamsters,” British Journal of Nutrition, vol. 112, no. 5, pp. 663–673, 2014. View at Publisher · View at Google Scholar
  • Claudia D. Fuchs, Thierry Claudel, and Michael Trauner, “Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD,” Trends in Endocrinology & Metabolism, 2014. View at Publisher · View at Google Scholar
  • Kenichiro Yasutake, Motoyuki Kohjima, Kazuhiro Kotoh, Manabu Nakashima, Makoto Nakamuta, and Munechika Enjoji, “Dietary habits and behaviors associated with nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1756–1767, 2014. View at Publisher · View at Google Scholar
  • Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci, and Guglielmo M Trovato, “4Ps medicine of the fatty liver: The research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics,” EPMA Journal, vol. 5, no. 1, 2014. View at Publisher · View at Google Scholar
  • Jiao-Ya Xu, Zhong-Ping Li, Li Zhang, and Guang Ji, “Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 37, pp. 13493–13500, 2014. View at Publisher · View at Google Scholar
  • Waseem Hassan, Gao Rongyin, Abdelkader Daoud, Lin Ding, Lulu Wang, Jun Liu, and Jing Shang, “Reduced Oxidative Stress Contributes to the Lipid Lowering Effects of Isoquercitrin in Free Fatty Acids Induced Hepatocytes,” Oxidative Medicine and Cellular Longevity, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Josep Maria del Bas, Antoni Caimari, Enzo Ceresi, Anna Arola-Arnal, Andreu Palou, Lluis Arola, and Anna Crescenti, “Differential effects of habitual chow-based and semi-purified diets on lipid metabolism in lactating rats and their offspring,” British Journal Of Nutrition, vol. 113, no. 5, pp. 758–769, 2015. View at Publisher · View at Google Scholar
  • Ji-Young Ann, Hyeyoon Eo, and Yunsook Lim, “Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice,” Genes And Nutrition, vol. 10, no. 6, 2015. View at Publisher · View at Google Scholar
  • Yun-liang Wang, Li-juan Liu, Wei-han Zhao, and Jun-xiang Li, “ Intervening TNF- α via PPAR γ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease ,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Yuchen Zhang, Jinyan Zhao, Xiaoyong Zhong, Haiyin Zheng, Ying Li, Liya Liu, Yun Wan, Jun Peng, and Zhenfeng Hong, “Ameliorative Potential Of Artemisia Capillaris Formula On Nonalcoholic Fatty Liver Disease In Rats Through Regulation Of Fat Metabolism,” African Journal Of Traditional Complementary And Alternative Medicines, vol. 12, no. 6, pp. 151–161, 2015. View at Publisher · View at Google Scholar
  • Donghee Kim, and W. Ray Kim, “Nonobese Fatty Liver Disease,” Clinical Gastroenterology and Hepatology, 2016. View at Publisher · View at Google Scholar
  • Ramesh Kumar, and Shantam Mohan, “Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications,” Journal of Clinical and Translational Hepatology, vol. XX, no. XX, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Bojan Jorgačević, Danijela Vučević, Ivana Đuričić, Slađana Šobajić, Dušan Mladenović, Milena Vesković, Rada Ješić Vukićević, and Tatjana Radosavljević, “The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease,” Chemistry and Physics of Lipids, 2017. View at Publisher · View at Google Scholar
  • Lihua Song, Dan Qu, Qing Zhang, Jing jiang, Haiyue Zhou, Rui Jiang, Yating Li, Yao Zhang, and Hongli Yan, “Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet,” Scientific Reports, vol. 7, pp. 41604, 2017. View at Publisher · View at Google Scholar
  • Yi Guo, Jun-Xiang Li, Tang-You Mao, Wei-Han Zhao, Li-Juan Liu, and Yun-Liang Wang, “Targeting sirt1 in a rat model of high‑fat diet‑induced non‑alcoholic fatty liver disease: Comparison of Gegen Qinlian decoction and resveratrol,” Experimental and Therapeutic Medicine, vol. 14, no. 5, pp. 4279–4287, 2017. View at Publisher · View at Google Scholar
  • Chun Kit Hung, and Henry C. Bodenheimer, “Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis,” Clinics in Liver Disease, 2017. View at Publisher · View at Google Scholar
  • Joel Vega-Badillo, “Alteraciones En La Homeostasis Del Colesterol Hepático Y Sus Implicaciones En La Esteatohepatitis No Alcohólica,” Tip, vol. 20, no. 1, pp. 50–65, 2017. View at Publisher · View at Google Scholar
  • Yi Guo, Jun-xiang Li, Yun-liang Wang, Tang-you Mao, Chen Chen, Tian-hong Xie, Ya-fei Han, Xiang Tan, and Hai-xiao Han, “Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • A. O. Bueverov, and P. O. Bogomolov, “Nonalcoholic fatty liver disease without obesity: the problem to be solved,” Terapevticheskii arkhiv, vol. 89, no. 12, pp. 226, 2017. View at Publisher · View at Google Scholar
  • Beatriz A. Sánchez-Jiménez, Diana Brizuela-Alcántara, Martha H. Ramos-Ostos, Luis F. Alva-López, Misael Uribe-Esquivel, and Norberto C. Chávez-Tapia, “Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis,” Alcohol, vol. 69, pp. 63–67, 2018. View at Publisher · View at Google Scholar
  • Alaknanda Mishra, Shailendra Arindkar, Preeti Sahay, Jerald Mahesh Kumar, Pramod K. Upadhyay, Subeer S. Majumdar, and Perumal Nagarajan, “Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model,” International Journal of Experimental Pathology, 2018. View at Publisher · View at Google Scholar
  • Husna Yetti, Hisao Naito, Yuan Yuan, Xiaofang Jia, Yumi Hayashi, Hazuki Tamada, Kazuya Kitamori, Katsumi Ikeda, Yukio Yamori, and Tamie Nakajima, “Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet,” Plos One, vol. 13, no. 2, pp. e0192863, 2018. View at Publisher · View at Google Scholar